OCUP

Filed a patent for "gene therapy for ocular disease" on Thu, January 5, 2023

Filed a patent for "gene therapy for ocular disease" on Mon, April 24, 2023

Filed a patent for "highly pure phentolamine mesylate and methods for making same" on Thu, September 19, 2024

Filed a patent for "highly pure phentolamine mesylate" on Thu, May 11, 2023

Filed a patent for "methods and compositions for daily ophthalmic administration of phentolamine to improve visual performance" on Thu, February 15, 2024

Filed a patent for "salts and esters of apx3330 and therapeutic uses thereof" on Thu, March 28, 2024

Filed a patent for "salts and esters of apx3330 and therapeutic uses thereof" on Thu, June 20, 2024

Filed a patent for "(2e)-2-[(4,5-dimethoxy-2-methyl-3,6-dioxo-1,4-cyclohexadien-1-yl)methylene]-undecanoic acid, salts and esters thereof, polymorphs thereof, and therapeutic uses thereof" on Wed, September 14, 2022

Filed a patent for "methods and compositions for treatment of presbyopia, mydriasis, and other ocular disorders" on Thu, July 21, 2022

Filed a patent for "highly pure phentolamine mesylate and methods for making same" on Thu, December 8, 2022

Filed a patent for "methods and compositions for treatment of mydriasis" on Thu, February 2, 2023

Filed a patent for "methods and compositions for treatment of mydriasis" on Thu, February 9, 2023